Skip to main content
PolicySpeak
← All files
IOP

Implandata Ophthalmic Products GmbH

Company · Germany

not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts (staff, costs, accreditations) are not available for it.

2
positions filed
in the 692 files tracked
1
legislative file
of 692 tracked
1
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 692 consultation files tracked so far (61,195 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Track Implandata in PolicySpeak: request access →

Follow Implandata Ophthalmic Products GmbH

An email when this organization files on a consultation we publish. Free with a PolicySpeak website account.

Work at Implandata Ophthalmic Products GmbH? so we know who speaks for it.

Their record over time

Implandata Ophthalmic Products GmbH filed 2 positions on 3 Oct 2025, across 1 of the 692 legislative files tracked here, attaching a full position paper 1 time.

What they argued

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 3 Oct 2025PDFsource

Implandata GmbH Feedback on the Targeted Revision of the MDR Implandata welcomes the Commission’s initiative to simplify and streamline the MDR. The way the MDR has been implemented places a disproportionate burden on SMEs and innovative companies. The result is delayed access to life-saving technologies, shrinking European competitiveness, and increasing device shortages. 1.

Opening of the attached position paper · the full paper is on the Commission’s record (source link above)

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 3 Oct 2025source

Implandata GmbH Feedback on the Targeted Revision of the MDR Implandata welcomes the Commissions initiative to simplify and streamline the MDR. The way the MDR has been implemented places a disproportionate burden on SMEs and innovative companies. The result is delayed access to life-saving technologies, shrinking European competitiveness, and increasing device shortages. 1.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put Implandata Ophthalmic Products GmbH next to another organization. Same files, same register facts, side by side. Compare →

Is this your organization?

Everything on this page comes from Implandata Ophthalmic Products GmbH’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.